fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
Published 7 years ago • 166 plays • Length 9:29
Download video MP4
Download video MP3
Similar videos
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
-
7:57
fda approvals in breast cancer and melanoma, disappointing results in hnscc, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
9:57
fda approvals in fl and rcc, breakthrough designation in myeloma, and more
-
10:42
fda approvals of a biosimilar and dtc genetic test, breakthrough designation in mzl, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
Clip.africa.com - Privacy-policy